Info
13F
Schedule 13D
Ownership

Cormorant Asset Management, LP (Bihua Chen) - Significant Ownership

Notable people: Bihua Chen
Signature - Title: /s/ CORMORANT ASSET MANAGEMENT, LP By: Cormorant Asset Management GP, LLC, its General Partner - By: Bihua Chen, Managing Member
Location: Boston, MA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Cormorant Asset Management, LP.

Significant Ownership of Cormorant Asset Management, LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VYNE	VYNE Therapeutics Inc.	Common Stock, par value $0.0001 per share	9.99%	$3.48M		1.85M		Cormorant Asset Management, LP	Mar 31, 2025
KALA	KALA BIO, Inc.	Common Stock, $0.001 par value per share	9.99%	$2.59M		609K		Cormorant Asset Management, LP	Dec 31, 2024
PRAX	Praxis Precision Medicines, Inc.	Common Stock, par value $0.0001 per share	8.57%	$64.9M	$1.93M	1.75M	+3.06%	Cormorant Asset Management, LP	Mar 31, 2025
BIOA	BioAge Labs, Inc.	Common Stock, par value $0.00001 per share	7.34%	$11.5M		2.63M		Cormorant Asset Management, LP	Dec 31, 2024
CRGX	CARGO Therapeutics, Inc.	Common stock, par value $0.001 per share	7.33%	$15.7M		3.38M		Cormorant Asset Management, LP	Mar 31, 2025
BMEA	Biomea Fusion, Inc.	Common Stock	6.46%	$6.63M		3.68M		Chen Bihua	Jun 20, 2025
OKUR	OnKure Therapeutics, Inc.	Class A Common Stock, par value $0.0001 per share	0%	$0		0		Cormorant Asset Management, LP	May 15, 2025

Showing 1 to 7 of 7 entries

Schedules 13D/G Reported by Cormorant Asset Management, LP:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.